Suppression of KRas-mutant cancer through the combined inhibition of KRAS with PLK1 and ROCK

por Wang, Jieqiong, Hu, Kewen, Guo, Jiawei, Cheng, Feixiong, Lv, Jing, Jiang, Wenhao, Lu, Weiqiang, Liu, Jinsong, Pang, Xiufeng, Liu, Mingyao
Publicado 2016

Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer

por Feng, Juanjuan, Lian, Zhengke, Xia, Xinting, Lu, Yue, Hu, Kewen, Zhang, Yunpeng, Liu, Yanan, Hu, Longmiao, Yuan, Kun, Sun, Zhenliang, Pang, Xiufeng
Publicado 2023

FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway

por Li, Kun, Guo, Qunfeng, Yang, Jun, Chen, Hui, Hu, Kewen, Zhao, Juan, Zheng, Shunxin, Pang, Xiufeng, Zhou, Sufang, Dang, Yongyan, Li, Lei
Publicado 2016

BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer

por Li, Kun, Liu, Yanan, Ding, Yi, Zhang, Zhengwei, Feng, Juanjuan, Hu, Jiaxin, Chen, Jiwei, Lian, Zhengke, Chen, Yiliang, Hu, Kewen, Chen, Zhi, Cai, Zhenyu, Liu, Mingyao, Pang, Xiufeng
Publicado 2022

CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse

por Guan, Yuting, Ma, Yanlin, Li, Qi, Sun, Zhenliang, Ma, Lie, Wu, Lijuan, Wang, Liren, Zeng, Li, Shao, Yanjiao, Chen, Yuting, Ma, Ning, Lu, Wenqing, Hu, Kewen, Han, Honghui, Yu, Yanhong, Huang, Yuanhua, Liu, Mingyao, Li, Dali
Publicado 2016